Diabetes medicine (FOI)

​Request

Can you please advise the following for a diabetes medicine called Ozempic (semaglutide):

A

Has funding been approved for GPs and Hospitals to prescribe semaglutide?

B

What is semaglutide's Red, Amber, Green (RAG) formulary status?

C

Is semaglutide positioned as 1, 2, 3 or 4th line GLP-1 on formulary (within it's RAG status)?

D

If semaglutide is approved for funding, what is date it was approved?

Response

A

Semaglutide is approved for prescribing by both GPs and the hospital.

B

Green.

C

Semaglutide is not positioned in relation to other GLP-1 (glucagon-like peptide 1) medicines. The decision on which one to prescribe is left to the clinical discretion of the prescriber.

D

Semaglutide was approved for prescribing in the hospital in April 2019 and for prescribing by GPs on 1 November 2019.